LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 Selumetinib
10.0
uM
LJP6
 72
hr
 1401 4192 4223 0.9927 0.9891
SK-BR-3 Sirolimus
10.0
uM
LJP6
 72
hr
 1401 2532 4223 0.5997 0.4009
SK-BR-3 Sorafenib
10.0
uM
LJP6
 72
hr
 1401 2693 4223 0.6378 0.4578
SK-BR-3 SU11274
10.0
uM
LJP5
 72
hr
 1401 1480 4223 0.3505 0.0278
SK-BR-3 Fedratinib
10.0
uM
LJP5
 72
hr
 1401 1116 4223 0.2643 -0.1011
SK-BR-3 TGX221
10.0
uM
LJP5
 72
hr
 1401 3799 4223 0.8996 0.8497
SK-BR-3 Torin1
10.0
uM
LJP6
 72
hr
 1401 1306 4223 0.3094 -0.0336
SK-BR-3 Torin2
10.0
uM
LJP5
 72
hr
 1401 1047 4223 0.2480 -0.1255
SK-BR-3 Tozasertib
10.0
uM
LJP5
 72
hr
 1401 1562 4223 0.3700 0.0571
SK-BR-3 Trametinib
10.0
uM
LJP5
 72
hr
 1401 3614 4223 0.8559 0.7843
SK-BR-3 TWS119
10.0
uM
LJP5
 72
hr
 1401 1527 4223 0.3617 0.0446
SK-BR-3 Vemurafenib
10.0
uM
LJP5
 72
hr
 1401 3594 4223 0.8510 0.7770
SK-BR-3 Withaferin A
10.0
uM
LJP5
 72
hr
 1401 1018 4223 0.2411 -0.1359
SK-BR-3 Withaferin A
10.0
uM
LJP6
 72
hr
 1401 1153 4223 0.2731 -0.0880
SK-BR-3 WYE-125132
10.0
uM
LJP6
 72
hr
 1401 1467 4223 0.3474 0.0232
SK-BR-3 WZ3105
10.0
uM
LJP5
 72
hr
 1401 992 4223 0.2349 -0.1451
SK-BR-3 XMD11-50
10.0
uM
LJP6
 72
hr
 1401 1955 4223 0.4629 0.1962
SK-BR-3 Y39983
10.0
uM
LJP6
 72
hr
 1401 1540 4223 0.3647 0.0491
SK-BR-3 YM 201636
10.0
uM
LJP5
 72
hr
 1401 1942 4223 0.4599 0.1917
SK-BR-3 ZSTK474
10.0
uM
LJP6
 72
hr
 1401 1564 4223 0.3705 0.0578